Vivos Therapeutics, Inc.
VVOS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001716166
No open-market purchases or sales by Vivos Therapeutics, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $242.7K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Vivos Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Vivos Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Sokolow Leonard J | Director | – | Sep 18, 2026 | 1 |
| Johnson Gregg C | Director | – | Sep 18, 2026 | 1 |
| Huntsman Ronald Kirk | Chief Executive Officer | 85,910Indirect | Sep 18, 2026 | 1 |
| Amman Bradford K. | Principal Accounting Officer | 250,080 | Aug 26, 2026 | 1 |
| Skaff Michael C | 10% Owner | 1,353,625Indirect | Jul 15, 2026 | 2 |
| V-Co Investors 3 LLC | 10% Owner | 1,353,625Indirect | Apr 2, 2026 | 1 |
| Krammer Anja B | Director | – | Jun 28, 2024 | 0 |
| Thompson Matthew | Director | – | Jun 28, 2024 | 0 |
| Lindsay Mark F. | Director | – | Jun 28, 2024 | 0 |
| Green Ralph Elias | Director | – | Jun 28, 2024 | 0 |
| Singh Gurdev Dave | Chief Medical Officer | – | Aug 10, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 (view filing)4:23 PM ET | Jun 30 | 15 daysLate | Skaff Michael C10% Owner | PPurchase | +5.50M | $0.582 | +$3.20M | –2.75M after | Derivative3 lots |
| Apr 2, 2026 (view filing)7:34 PM ET | Mar 31 | 2 days | Skaff Michael C and 1 other10% Owner | PPurchase | +1.35M | $1.34 | +$1.81M | New position1.35M after | 2 lots |
| Apr 2, 2026 (view filing)7:34 PM ET | Mar 31 | 2 days | Skaff Michael C and 1 other10% Owner | PPurchase | +4.00M | $1.34 | +$5.36M | –1.78M after | Derivative3 lots |
| Jun 20, 2023 (view filing) | Jun 20 | Same day | Huntsman Ronald KirkChief Executive Officer | PPurchase | +14.0K | $0.53 | +$7.42K | +19.3%86.5K after | |
| Jun 20, 2023 (view filing) | Jun 15-16 | 5 days | Huntsman Ronald KirkChief Executive Officer | PPurchase | +15.0K | $0.5366 | +$8.06K | +26.1%72.5K after | 3 lots |
| Jun 15, 2023 (view filing)7:15 PM ET | Jun 14 | 1 day | Huntsman Ronald KirkChief Executive Officer | PPurchase | +10.0K | $0.49 | +$4.90K | +21.1%57.5K after | |
| Dec 28, 2022 (view filing)9:45 PM ET | Dec 23 | 5 days | Huntsman Ronald KirkChief Executive Officer | PPurchase | +20.0K | $0.50 | +$10.0K | +72.7%47.5K after | |
| Jun 3, 2022 (view filing) | May 31-Jun 1 | 3 daysLate | Huntsman Ronald KirkChief Executive Officer | PPurchase | +12.0K | $1.96 | +$23.6K | +77.4%27.5K after | 2 lots |
| Sep 22, 2021 (view filing) | Sep 21 | 1 day | Huntsman Ronald KirkChief Executive Officer | PPurchase | +5.00K | $4.31 | +$21.6K | +47.6%15.5K after | |
| Aug 18, 2021 (view filing) | Aug 17 | 1 day | Huntsman Ronald KirkChief Executive Officer | PPurchase | +5.00K | $3.00 | +$15.0K | +90.9%10.5K after |